ArticleJournal of managed care & specialty pharmacy2019

Utilization Patterns of Oral Disease-Modifying Drugs in Commercially Insured Patients with Multiple Sclerosis.

Rishi J Desai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.